New approach aims to boost HIV prevention in latine communities
NCT ID NCT07218211
Summary
This study is testing whether offering a long-acting injectable HIV prevention medication (lenacapavir) through a trusted community organization helps Latine gay/bisexual men and transgender women stay on the medication longer. The program provides culturally-tailored support through peer navigators at El Centro Hispano. Researchers want to see if this community-based approach works better than traditional clinic settings for this population.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PRE-EXPOSURE PROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
El Centro Hispano
RECRUITINGDurham, North Carolina, 27701, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.